Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
6.41
-0.01 (-0.16%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Lyra Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lyra Therapeutics stock has a target of 16, which predicts a 149.61% increase from the current stock price of 6.41.
Price Target: $16 (+149.61%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 14, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Lyra Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 3 | 3 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $16 | Hold | Reiterates | $16 | +149.61% | Aug 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $2 → $16 | Hold | Maintains | $2 → $16 | +149.61% | Jun 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $100 | Hold | Reiterates | $100 | +1,460.06% | Mar 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $100 | Hold | Reiterates | $100 | +1,460.06% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
775.97K
from 1.53M
Decreased by -49.42%
Revenue Next Year
1.73M
from 775.97K
Increased by 123.46%
EPS This Year
-9.25
from -71.75
EPS Next Year
-9.79
from -9.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6M | 4.2M | |||
| Avg | 775,965 | 1.7M | |||
| Low | 392,000 | 392,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.7% | 441.3% | |||
| Avg | -49.4% | 123.5% | |||
| Low | -74.4% | -49.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.54 | -6.57 | |
| Avg | -9.25 | -9.79 | |
| Low | -20.58 | -15.19 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.